- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.07. | NSE - DermTech, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
| 16.07. | Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON Pharmaceuticals ... | 55 | GlobeNewswire (Europe) | NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of CONX Corp. CONX Corp.'s securities were suspended on... ► Artikel lesen | |
| 24.06. | Why Is DermTech (DMTK) Stock Down 26% Today? | 1 | InvestorPlace | ||
| 18.06. | Crude Oil Rises 1%; DermTech Shares Plummet | 1 | Benzinga.com | ||
| 18.06. | DermTech shares sink after filing for bankruptcy | 3 | Reuters | ||
| 18.06. | DermTech files for chapter 11 bankruptcy protection | 1 | Seeking Alpha | ||
| 18.06. | DermTech, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.05. | DermTech, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | DermTech Inc reports results for the quarter ended in March - Earnings Summary | 4 | Reuters | ||
| 15.05. | DermTech, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.05. | DermTech GAAP EPS of -$0.58, revenue of $3.85M | 2 | Seeking Alpha | ||
| 14.05. | DermTech Reports First-Quarter 2024 Financial Results | 121 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its first-quarter... ► Artikel lesen | |
| 10.05. | DermTech, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.04. | What Analysts Are Saying About DermTech Stock | 3 | Benzinga.com | ||
| 18.04. | DermTech exploring strategic alternatives, cutting 56% of staff | 6 | Seeking Alpha | ||
| 16.04. | DermTech, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.03. | DermTech, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 4 | SEC Filings | ||
| 06.03. | DermTech shares target cut to $2 on revised growth outlook | 7 | Investing.com | ||
| 05.03. | Stephens cuts DermTech stock target to $1.50, keeps Equal Weight rating | 4 | Investing.com | ||
| 01.03. | Earnings call: DermTech posts strong Q4 results, aims to optimize costs | 6 | Investing.com |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 31,860 | 0,00 % | Fresenius: Dank defensiver Qualitäten zum Outperformer | Die Aktie von Fresenius hat sich zuletzt als einer der Outperformer im DAX entpuppt. Charttechnisch sieht es jetzt spannend aus. Der Kurs steht direkt vor einer wichtigen Hürde und könnte mittelfristig... ► Artikel lesen | |
| ECKERT & ZIEGLER | 43,360 | +2,12 % | Eckert&Ziegler-Aktie leicht im Minus (43,00 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Eckert&Ziegler derzeit im Minus. Zuletzt zahlten Investoren für die Aktie 43,00 Euro. Ein Wertverlust in Höhe von 1,54 Euro müssen derzeit die... ► Artikel lesen | |
| UNITEDHEALTH | 525,20 | +0,08 % | Unitedhealth Aktie: Insiderverkäufe beeinflussen Marktbewertung | UnitedHealth Group, ein führendes Unternehmen im US-Gesundheitssektor, verzeichnet bedeutende Insiderverkäufe. Thomas Roos, Chief Accounting Officer, veräußerte kürzlich 2.851 Aktien, während Erin McSweeney... ► Artikel lesen | |
| HIMS & HERS HEALTH | 20,420 | +1,85 % | How Is The Market Feeling About Hims & Hers Health? | ||
| INMODE | 16,455 | -0,12 % | Jefferies cuts Inmode to hold, cites macro pressures | ||
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| AMBU | 18,310 | +0,03 % | Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities | Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report |
Das Unternehmen DERMTECH INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,094 Euro und damit -0,11 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DERMTECH INC finden Sie auf Wallstreet Online.
